Outcomes of sexagenarian living liver donors in Korea: A multicenter study

被引:3
|
作者
Kim, Jong Man [1 ]
Joo, Dong Jin [2 ]
Hong, Suk Kyun [3 ]
You, Young Kyoung [4 ]
Hwang, Shin [5 ]
Ryu, Je Ho [6 ]
Kim, Doo Jin [7 ]
Yu, Hee Chul [8 ]
Nah, Yang Won [9 ]
Kim, Myoung Soo [3 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Surg, 101 Daehakro, Seoul 03080, South Korea
[4] Catholic Univ Korea, Coll Med, Dept Surg, 222 Banpo Daero, Seoul 06591, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[6] Pusan Natl Univ, Coll Med, Dept Surg, Busan, South Korea
[7] Gachon Univ, Coll Med, Gil Med Ctr, Dept Surg, Incheon, South Korea
[8] Chonbuk Natl Univ, Med Sch, Dept Surg, Jeonju, South Korea
[9] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Surg, Ulsan, South Korea
关键词
TRANSPLANTATION; RISK; AGE; IMPACT; OLD;
D O I
10.1097/LVT.0000000000000104
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The safety of elderly living liver donors and recipient outcomes are always of concern. In the present study, the effects of age in 2 donor groups, a 60+years old group and a 50-59 years old group (referred to as the 60s and 50s donor groups, respectively), on living donor liver transplantation were compared regarding donor safety and recipient outcomes. We retrospectively identified 209 patients 50 years and above of age at 9 centers from 2005 to 2017 in Korea. The 60s donor group represented 10% (n=21) of donor patients. One case in each group was a left liver graft, respectively, and the others were right liver grafts. Postoperative complications were more common in the 60s donor group, but the proportion of Clavien-Dindo grade III in the 60s donor group did not differ from that in the 50s donor group. In-hospital mortality did not occur among donors, and donor mortality was not reported during the observation period. Postoperative total bilirubin and hospitalization in recipients of the 60s donor group were higher and longer than in recipients of the 50s donor group, respectively. Although the cumulative overall survival of the recipients in the 60s donor group was significantly lower than that of the 50s donor group, a difference was not observed in graft survival. Multivariate analysis showed that increased living liver donors age, the coexistence of HCC, and increased intraoperative blood loss during the recipient operation were important predisposing factors for patient death.Present study suggests that highly selected elderly living donors (& GE;60 y) can safely donate with similar recipient graft survival rates though the recipient overall patient survival is inferior compared to the 50s donor group.
引用
收藏
页码:698 / 710
页数:13
相关论文
共 50 条
  • [1] Outcomes Among Living Liver Donors
    Trotter, James F.
    Everhart, James E.
    GASTROENTEROLOGY, 2012, 142 (02) : 207 - 210
  • [2] Mental and Physical Quality of Life in Actual Living Liver Donors Versus Potential Living Liver Donors: A Prospective, Controlled, Multicenter Study
    Schulz, Karl-Heinz
    Kroencke, Sylvia
    Beckmann, Mingo
    Nadalin, Silvio
    Paul, Andreas
    Fischer, Lutz
    Nashan, Bjoern
    Senf, Wolfgang
    Erim, Yesim
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1676 - 1687
  • [3] Outcomes of living donor liver transplantation using elderly donors
    Han, Jae Hyun
    You, Young Kyoung
    Na, Gun Hyung
    Kim, Eun Young
    Lee, Soo Ho
    Hong, Tae Ho
    Kim, Dong Goo
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2014, 86 (04) : 184 - 191
  • [4] Recipient Outcomes with Younger Donors Undergoing Living Donor Liver Transplantation
    Dar, Faisal S.
    Khan, Nusrat Y.
    Ali, Rubab
    Khokhar, Hamzah Khawar
    Zia, Haseeb H.
    Bhatti, Abu Bakar H.
    Shah, Najmul H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (03)
  • [5] What are 'true normal' liver stiffness values using FibroScan®?: a prospective study in healthy living liver and kidney donors in South Korea
    Kim, Seung Up
    Choi, Gi Hong
    Han, Woong Kyu
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Choi, Jin Sub
    Yang, Seung Choul
    Choi, Eun Hee
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Chon, Chae Yoon
    LIVER INTERNATIONAL, 2010, 30 (02) : 268 - 274
  • [6] Platelet count reduction and outcomes in living liver donors
    Lei, Jian-Yong
    Wang, Wen-Tao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2014, 13 (01) : 25 - 31
  • [7] Short-term and long-term outcomes in living donors for liver transplantation: Cohort study
    Takagi, Kosei
    Umeda, Yuzo
    Yoshida, Ryuichi
    Watanabe, Nobuyuki
    Kuise, Takashi
    Yoshida, Kazuhiro
    Yasui, Kazuya
    Matsuda, Tatsuo
    Fujiwara, Toshiyoshi
    Yagi, Takahito
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 84 : 147 - 153
  • [8] Defining Benchmarks for Major Liver Surgery A multicenter Analysis of 5202 Living Liver Donors
    Rossler, Fabian
    Sapisochin, Gonzalo
    Song, GiWon
    Lin, Yu-Hung
    Simpson, Mary Ann
    Hasegawa, Kiyoshi
    Laurenzi, Andrea
    Sanchez Cabus, Santiago
    Nunez, Milton Inostroza
    Gatti, Andrea
    Chahdi Beltrame, Magali
    Slankamenac, Ksenija
    Greig, Paul D.
    Lee, Sung-Gyu
    Chen, Chao-Long
    Grant, David R.
    Pomfret, Elizabeth A.
    Kokudo, Norihiro
    Cherqui, Daniel
    Olthoff, Kim M.
    Shaked, Abraham
    Garcia-Valdecasas, Juan Carlos
    Lerut, Jan
    Troisi, Roberto I.
    De Santibanes, Martin
    Petrowsky, Henrik
    Puhan, Milo A.
    Clavien, Pierre-Alain
    ANNALS OF SURGERY, 2016, 264 (03) : 492 - 500
  • [9] Outcomes and technical aspects of liver retransplantation with living donors in children
    Feier, Flavia
    da Fonseca, Eduardo A.
    Candido, Helry L.
    Pugliese, Renata
    Benavides, Marcel R.
    Neiva, Romerito
    Chapchap, Paulo
    Seda-Neto, Joao
    PEDIATRIC TRANSPLANTATION, 2016, 20 (06) : 813 - 818
  • [10] Positive autoantibodies in living liver donors
    Loh, Joyce
    Hashimoto, Koji
    Kwon, Choon Hyuck David
    Fujiki, Masato
    Esfeh, Jamak Modaresi
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (09) : 1757 - 1766